$GSTX
Graphene & Solar Technologies Ltd

2023 Q2 Form 10-K Financial Statement

#000190359623000299 Filed on April 12, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q3 2022
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $398.3K $1.300M $15.02M
YoY Change -10.51% -95.63% -56.63%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $80.00 $247.9K $829.00
YoY Change -99.97% 142.29% -99.28%
% of Gross Profit
Operating Expenses $398.3K $1.300M $15.02M
YoY Change -10.51% -95.64% -56.68%
Operating Profit -$398.3K -$15.02M
YoY Change -56.68%
Interest Expense $5.375K -$4.940K $35.26K
YoY Change 9.9% -77.66% -123.32%
% of Operating Profit
Other Income/Expense, Net $2.789K $6.420K -$5.998M
YoY Change -216.35% 41.41% -38300.86%
Pretax Income -$395.5K -$7.286M -$7.797M
YoY Change -10.65% -75.57% -77.6%
Income Tax
% Of Pretax Income
Net Earnings $395.5K -$7.286M -$21.02M
YoY Change -189.35% -75.57% -39.63%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 -$0.02 -$0.06
COMMON SHARES
Basic Shares Outstanding 374.5M shares 362.8M shares
Diluted Shares Outstanding 384.0M shares

Balance Sheet

Concept 2023 Q2 2022 Q3 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.500K $2.860K $2.860K
YoY Change 98.78% -23.32% -23.32%
Cash & Equivalents $6.495K $2.857K
Short-Term Investments
Other Short-Term Assets $11.40K $11.18K $11.18K
YoY Change -37.53% -40.53% -40.53%
Inventory
Prepaid Expenses $11.40K $11.18K
Receivables
Other Receivables
Total Short-Term Assets $17.90K $14.04K $14.04K
YoY Change -16.84% -37.67% -37.68%
LONG-TERM ASSETS
Property, Plant & Equipment $1.047K $1.273K $1.270K
YoY Change -33.27% -43.42% -43.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $6.038K $4.342K $4.340K
YoY Change -99.9% -99.94% -99.94%
TOTAL ASSETS
Total Short-Term Assets $17.90K $14.04K $14.04K
Total Long-Term Assets $6.038K $4.342K $4.340K
Total Assets $23.94K $18.38K $18.38K
YoY Change -99.61% -99.73% -99.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.551M $2.381M $2.381M
YoY Change 6.32% 8.31% 8.31%
Accrued Expenses $177.1K $161.6K $161.6K
YoY Change 3.28% 4.66% 4.66%
Deferred Revenue
YoY Change
Short-Term Debt $212.4K $177.0K $177.0K
YoY Change -15.62% -26.07% -26.07%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.778M $4.062M $4.062M
YoY Change 18.63% 14.75% 14.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.778M $4.062M $4.062M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $4.778M $4.062M $4.062M
YoY Change 18.63% 14.75% 14.75%
SHAREHOLDERS EQUITY
Retained Earnings -$67.84M -$67.07M
YoY Change 13.48% 45.64%
Common Stock $3.854K $3.748K
YoY Change 6.08% 9.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.754M -$4.043M -$4.043M
YoY Change
Total Liabilities & Shareholders Equity $23.94K $18.38K $18.38K
YoY Change -99.61% -99.73% -99.73%

Cashflow Statement

Concept 2023 Q2 2022 Q3 2022
OPERATING ACTIVITIES
Net Income $395.5K -$7.286M -$21.02M
YoY Change -189.35% -75.57% -39.63%
Depreciation, Depletion And Amortization $80.00 $247.9K $829.00
YoY Change -99.97% 142.29% -99.28%
Cash From Operating Activities -$3.060K $5.640K -$43.82K
YoY Change 774.29% -105.54% -86.31%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $46.92K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.800K 0.000 $46.92K
YoY Change -100.0% -82.69%
NET CHANGE
Cash From Operating Activities -3.060K 5.640K -$43.82K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 9.800K 0.000 $46.92K
Net Change In Cash 6.740K 5.640K -$871.00
YoY Change -2025.71% -105.37% -98.32%
FREE CASH FLOW
Cash From Operating Activities -$3.060K $5.640K -$43.82K
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$3.060K $5.640K -$43.82K
YoY Change 774.29% -105.68% -86.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
333-174194
CY2022 dei Entity Registrant Name
EntityRegistrantName
GRAPHENE & SOLAR TECHNOLOGIES LIMITED
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001497649
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
usd
CY2022Q3 gstx Intellectual Property At Cost
IntellectualPropertyAtCost
usd
CY2022Q3 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022 us-gaap Revenues
Revenues
usd
CY2021 us-gaap Revenues
Revenues
usd
CY2021 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
usd
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
usd
CY2021 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
usd
CY2021 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
usd
CY2022 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
usd
CY2021 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
usd
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022 us-gaap Asset Acquisition Consideration Transferred Transaction Cost
AssetAcquisitionConsiderationTransferredTransactionCost
usd
CY2022 gstx Note Payable Converted Into Common Stock
NotePayableConvertedIntoCommonStock
usd
CY2022 gstx Debt Discount On Convertible Notes
DebtDiscountOnConvertibleNotes
usd
CY2021 gstx Settlement Of Debt For Common Stock
SettlementOfDebtForCommonStock
usd
CY2021Q3 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
usd
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2888719
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
23 Corporate Plaza Drive
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
suite 150
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Newport Beach
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92660
CY2022 dei City Area Code
CityAreaCode
949
CY2022 dei Local Phone Number
LocalPhoneNumber
478-8387
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Public Float
EntityPublicFloat
38307530 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
374542610 shares
CY2022 dei Auditor Name
AuditorName
M&K CPAS, PLLC
CY2022 dei Auditor Firm
AuditorFirmId
2738
CY2022 dei Auditor Location
AuditorLocation
Houston, TX
CY2022Q3 us-gaap Cash
Cash
2857 usd
CY2021Q3 us-gaap Cash
Cash
3728 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11183 usd
CY2021Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18797 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
14040 usd
CY2021Q3 us-gaap Assets Current
AssetsCurrent
22525 usd
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
77251 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1273 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2250 usd
CY2022Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
2094 usd
CY2021Q3 gstx Intellectual Property At Cost
IntellectualPropertyAtCost
6777424 usd
CY2022Q3 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
975 usd
CY2021Q3 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
975 usd
CY2022Q3 us-gaap Assets
Assets
18382 usd
CY2021Q3 us-gaap Assets
Assets
6803174 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2380565 usd
CY2021Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2197894 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
161602 usd
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
154412 usd
CY2022Q3 gstx Due To Related Parties Current One
DueToRelatedPartiesCurrentOne
1342405 usd
CY2021Q3 gstx Due To Related Parties Current One
DueToRelatedPartiesCurrentOne
947826 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
76255 usd
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
60000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
0 usd
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
76255 usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
100747 usd
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
173038 usd
CY2021Q3 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
6383 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4061574 usd
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3539553 usd
CY2022Q3 us-gaap Liabilities
Liabilities
4061574 usd
CY2021Q3 us-gaap Liabilities
Liabilities
3539553 usd
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
374305480 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
343237369 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
3748 usd
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
3437 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63527513 usd
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
49922922 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67070016 usd
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46050640 usd
CY2022Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
795000 usd
CY2021Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
720000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
290563 usd
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
107902 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-4043192 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3263621 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18382 usd
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6803174 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
13912620 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
34377901 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1109221 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
301543 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
15021841 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
34679444 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-15021841 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-34679444 usd
CY2022 us-gaap Interest Expense
InterestExpense
35262 usd
CY2021 us-gaap Interest Expense
InterestExpense
151203 usd
CY2022 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
24982 usd
CY2021 us-gaap Rental Income Nonoperating
RentalIncomeNonoperating
15703 usd
CY2022 gstx Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
-192652 usd
CY2022 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
5794603 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5997535 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-135500 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-21019376 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-34814944 usd
CY2022 gstx Foreign Currency Translation Adjustment
ForeignCurrencyTranslationAdjustment
182661 usd
CY2021 gstx Foreign Currency Translation Adjustment
ForeignCurrencyTranslationAdjustment
-55887 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-20836715 usd
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-34870831 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20836715 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-34870831 usd
CY2022 gstx Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.06
CY2021 gstx Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.14
CY2022 gstx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
363203503 shares
CY2021 gstx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
257521936 shares
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-1672275 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
138093 usd
CY2021 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
33793499 usd
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
204410 usd
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
5558951 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
55887 usd
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-34814944 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3263621 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
46921 usd
CY2022 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
13207981 usd
CY2022 gstx Settlement Of Notes
SettlementOfNotes
275000 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
182661 usd
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-21019376 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-4043192 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-21019376 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-34814944 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13207981 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33793499 usd
CY2022 gstx Loss On Settlement Of Debt
LossOnSettlementOfDebt
192652 usd
CY2022 gstx Amortization Expenses
AmortizationExpenses
982821 usd
CY2021 gstx Amortization Expenses
AmortizationExpenses
102321 usd
CY2022 us-gaap Depreciation
Depreciation
829 usd
CY2021 us-gaap Depreciation
Depreciation
12504 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
13943 usd
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
122130 usd
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
518543 usd
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
231110 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
5794603 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6403 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-19337 usd
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-2094 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
238554 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
224227 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
21318 usd
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
28363 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43823 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-320127 usd
CY2021 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
1883 usd
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
975 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2858 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
46921 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
138093 usd
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
133005 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46921 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
271098 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-3969 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55603 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-871 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3716 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3728 usd
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2857 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3728 usd
CY2021 us-gaap Asset Acquisition Consideration Transferred Transaction Cost
AssetAcquisitionConsiderationTransferredTransactionCost
7599745 usd
CY2021 gstx Note Payable Converted Into Common Stock
NotePayableConvertedIntoCommonStock
127050 usd
CY2021 gstx Debt Discount On Convertible Notes
DebtDiscountOnConvertibleNotes
77360 usd
CY2022 gstx Settlement Of Debt For Common Stock
SettlementOfDebtForCommonStock
82348 usd
CY2022 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2010-06-21
CY2022Q3 gstx Cash One
CashOne
2857 usd
CY2022 us-gaap Increase Decrease In Due From Officers And Stockholders Current
IncreaseDecreaseInDueFromOfficersAndStockholdersCurrent
720000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_zxUz3nQQVG9h" style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.05pt; text-align: justify"><span id="xdx_863_zYrC8aITlopl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates. Significant estimates include those related to assumptions used in accruals for potential liabilities, valuing equity instruments issued for services, and the realization of deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 1.05pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
102231 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2857 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3728 usd
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
60000 usd
CY2022Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
100747 usd
CY2021Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
173038 usd
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
28868111 shares
CY2021 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
12888596 shares
CY2022 gstx Stock Based Compensation Expense
StockBasedCompensationExpense
13207981 usd
CY2021 gstx Stock Based Compensation Expense
StockBasedCompensationExpense
5158500 usd
CY2022Q3 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
0.6502 pure
CY2021Q3 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
0.7206 pure
CY2022Q3 gstx Average Aud Usd Exchange Rate
AverageAudUsdExchangeRate
0.7126 pure
CY2021Q3 gstx Average Aud Usd Exchange Rate
AverageAudUsdExchangeRate
0.7508 pure
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
76255 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
78524 usd
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
87026 usd
CY2022Q3 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
77251 usd
CY2021Q3 us-gaap Property Plant And Equipment Excluding Lessor Asset Under Operating Lease Accumulated Depreciation
PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation
84776 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1273 usd
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2250 usd
CY2022 us-gaap Depreciation
Depreciation
829 usd
CY2021 us-gaap Depreciation
Depreciation
12504 usd
CY2022Q3 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
6777424 usd
CY2021Q3 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
6879655 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-982821 usd
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-102231 usd
CY2022Q3 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
5794602 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1 usd
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6777424 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
982821 usd
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
374305480 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
343237369 shares
CY2022Q3 gstx Due To Related Parties Current Two
DueToRelatedPartiesCurrentTwo
1342405 usd
CY2021Q3 gstx Due To Related Parties Current Two
DueToRelatedPartiesCurrentTwo
947826 usd
CY2022 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
21019376 usd
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
13207981 usd
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
13943 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-7797452 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-899315 usd
CY2022Q3 gstx Operating Loss Carryforward
OperatingLossCarryforward
4432494 usd
CY2021Q3 gstx Operating Loss Carryforward
OperatingLossCarryforward
2751946 usd
CY2022Q3 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
4432494 usd
CY2021Q3 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
2751946 usd

Files In Submission

Name View Source Status
0001903596-23-000299-index-headers.html Edgar Link pending
0001903596-23-000299-index.html Edgar Link pending
0001903596-23-000299.txt Edgar Link pending
0001903596-23-000299-xbrl.zip Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gstx-20220930.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gstx_10k.htm Edgar Link pending
image_001.gif Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
gstx-20220930_cal.xml Edgar Link unprocessable
gstx-20220930_def.xml Edgar Link unprocessable
gstx-20220930_pre.xml Edgar Link unprocessable
gstx-20220930_lab.xml Edgar Link unprocessable
gstx_10k_htm.xml Edgar Link completed